New Day Diagnostics
Manufacturing · Tennessee, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
University of Tennessee Research Park at...Website
www.newdaydiagnostics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About New Day Diagnostics
New Day Diagnostics specializes in early-stage diagnostics, focusing on making screening for diseases like colorectal cancer simple, affordable, and accessible through their innovative product, ColoHealth. They provide non-invasive, blood-based diagnostic tests that significantly improve patient compliance and early detection rates. The company also offers specialized R&D partnership services to accelerate the development and commercialization of novel diagnostic technologies. With a commitment to operational excellence and rigorous clinical validation, New Day Diagnostics aims to transform access to health information and expand their diagnostic capabilities across various disease states.Explore more
New Day Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is New Day Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if New Day Diagnostics has recently received funding, and reach out quickly before it becomes old news!
New Day Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at New Day Diagnostics
Check out if New Day Diagnostics is spiking on competitors!
Earning: See what the market has to say on New Day Diagnostics recently announced quarterly report
Click to see if New Day Diagnostics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once New Day Diagnostics has new funding data
Product Launch: Get notified when New Day Diagnostics launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to New Day Diagnostics
Compare insights from companies similar to New Day Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
New Day Diagnostics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
New Day Diagnostics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about New Day Diagnostics.
New Day Diagnostics Tech Stack
A closer look at the technologies used by New Day Diagnostics
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Person-Based
Person-Based
Person-Based
Mergers & Acquisitions (M&A)
New Day Diagnostics News & Media
Daisy Genomics and New Day Diagnostics Partner to Advance CRC Detection With University of Tennessee Support
KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day Diagnostics (“New Day”) have announced a strategic research collaboration focused on cancer diagnostics, launched in partnership with …Augurex and New Day Diagnostics Announce Launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents; Enabling a First-In-Class Diagnostic Test for Axial Spondyloarthritis
VANCOUVER, British Columbia & KNOXVILLE, Tenn.--(BUSINESS WIRE)-- #AxialSpondyloarthritis--Augurex Life Sciences Corp. (“Augurex”) today announced the launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents (ASRs), supporting the development of a first-in-class diagnostic test that assists clinicians in the diagnosis of axial spondyloarthritis (axSpA). New Day Diagnostics in Knoxville, TN, developed the diagnostic test using the Anti-14-3-3eta Multiplex ASRs as components and now offers theNew Day Diagnostics Announces Approval of Purchase Agreement by Epigenomics' AG Extraordinary General Meeting
KNOXVILLE, Tenn.--(BUSINESS WIRE)--New Day Diagnostics is pleased to announce that the Extraordinary General Meeting of Epigenomics AG (Frankfurt General Standard: ECX1), a molecular diagnostics company focused on blood testing for the early detection of cancer, has approved the acquisition agreement between the two organizations. The agreement's completion will further enhance New Day Diagnostics' ability to improve lives by empowering people with innovative, accessible diagnostics. “New Day DNew Day Diagnostics LLC Reinforces Commitment to Early Cancer Intervention with Its intention to Acquire the Assets of Epigenomics AG
KNOXVILLE, Tenn.--(BUSINESS WIRE)--New Day Diagnostics LLC is pleased to announce that it has entered into an asset purchase agreement with Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), a molecular diagnostics company focused on blood testing for the early detection of cancer. This agreement is the successful result of negotiations previously disclosed by Epigenomics AG in their ad hoc announcement dated June 12, 2023. Today's announcement comes on the heels of New Day Diagnosti
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding New Day Diagnostics
Sign Up For FreeTo access detailed company insights
New Day Diagnostics specializes in early-stage diagnostics, focusing on making screening for diseases like colorectal cancer simple, affordable, and accessible through their innovative product, ColoHealth. They provide non-invasive, blood-based diagnostic tests that significantly improve patient compliance and early detection rates. The company als... Read More
